Pregnancy: Clinical data of CILANEM on pregnancy are very limited, Animal studies are insufficient to draw conclusion for pregnancy, embryonal/foetal development, parturition or postnatal development.
The potential risk for human is unknown. CILANEM should not be used during pregnancy unless clearly necessary.
Lactation: It is not known whether CILANEM is excreted in human breast milk. A study in rats has shown that CILANEM and its metabolite are transferred to milk. A decision on whether to continue/discontinue breast-feeding or to continue/discontinue therapy with CILANEM should be made taking into account the benefit of breastfeeding to the child and the benefit of CILANEM therapy to the woman.
Other Services
Country
Account
Sign Out